As the mRNA-injection does not prevent the spread of the virus (since it's neither sterilising nor immunising), the question whether injections saved lives is moot, unless looked at by taking comorbidity relevant to risk of Covid infection/consequence thereof into account.
Say someone undergoing treatment for hairy cell cancer - their im…
As the mRNA-injection does not prevent the spread of the virus (since it's neither sterilising nor immunising), the question whether injections saved lives is moot, unless looked at by taking comorbidity relevant to risk of Covid infection/consequence thereof into account.
Say someone undergoing treatment for hairy cell cancer - their immune system is weak and unresponsive, so they'd be at great risk both at becoming infected and suffering severe infection.
So any protection from the injection might be a net gain for that patient/group of patients.
While for a fat diabetic with a known history of blood clots, it might be the opposite.
Then again, I have no medical training nor am I a professional researcher so maybe I'm missing something obvious, but shouldn't the least and most vulnerable groups be the ones most interesting to look at?
If effective early treatment is made readily available instead of being blocked, virtually any risk from vaccination is unnecessary and too much. The death rate among high risk patients who get skillful early treatment is extremely low, and this was true even with the Wuhan and Delta strains. I think Zelenko, and Tyson and Fareed, lost less than one patient per thousand. And this doesn't take prophylaxis using HCQ+zinc or IVM into account.
As the mRNA-injection does not prevent the spread of the virus (since it's neither sterilising nor immunising), the question whether injections saved lives is moot, unless looked at by taking comorbidity relevant to risk of Covid infection/consequence thereof into account.
Say someone undergoing treatment for hairy cell cancer - their immune system is weak and unresponsive, so they'd be at great risk both at becoming infected and suffering severe infection.
So any protection from the injection might be a net gain for that patient/group of patients.
While for a fat diabetic with a known history of blood clots, it might be the opposite.
Then again, I have no medical training nor am I a professional researcher so maybe I'm missing something obvious, but shouldn't the least and most vulnerable groups be the ones most interesting to look at?
If effective early treatment is made readily available instead of being blocked, virtually any risk from vaccination is unnecessary and too much. The death rate among high risk patients who get skillful early treatment is extremely low, and this was true even with the Wuhan and Delta strains. I think Zelenko, and Tyson and Fareed, lost less than one patient per thousand. And this doesn't take prophylaxis using HCQ+zinc or IVM into account.